Monopar Therapeutics Inc. (MNPR)

SEC filing

Monopar Therapeutics Inc.

MNPR · CIK 1645469

4 · Oct 2, 2026 · Director, Chief Executive Officer Robinson Chandler exercised options for 19.60K shares; reported 4,344 shares

Director, Chief Executive Officer Robinson Chandler exercised options for 19.60K shares; reported 4,344 shares

FORM 4

xslF345X06/rdgdoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).